Yield10 Bioscience (YTEN) Stock Price, News & Analysis

Company Overview

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

Key Stats

• Today's Range: $0.0150 to $0.0150
• 50-Day Range: $0.0010 to $0.0150
• 52-Week Range: $0.31 to $17.26
• Volume: 79 shs
• Average Volume: 78,164 shs
• Market Capitalization: $11,010.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

YTEN Stock Analysis - Frequently Asked Questions

How have YTEN shares performed this year?

Yield10 Bioscience's stock was trading at $0.3120 at the beginning of 2025. Since then, YTEN stock has decreased by 95.2% and is now trading at $0.0150.
View the best growth stocks for 2025 here.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced its quarterly earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) EPS for the quarter, beating the consensus estimate of ($15.60) by $3.84. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to analysts' expectations of $0.22 million.

When did Yield10 Bioscience's stock split?

Shares of Yield10 Bioscience reverse split on the morning of Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), KushCo (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL).

Company Calendar

• Last Earnings: 11/09/2021
• Today: 3/29/2025
• Next Earnings (Estimated): 5/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: NASDAQ:YTEN
• CIK: 1121702
• Web: www.yield10bio.com
• Phone: (617) 583-1700
• Fax: 617-583-1768
• Employees: 30
• Year Founded: 1992

Profitability

• EPS (Most Recent Fiscal Year): ($26.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-14,450,000.00
• Net Margins: N/A
• Pretax Margin: -1,693.60%
• Return on Equity: N/A
• Return on Assets: -296.08%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $60,000.00
• Price / Sales: 0.18
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($4.97) per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 734,000
• Free Float: 689,000
• Market Cap: $11,010.00
• Optionable: Not Optionable
• Beta: 1.48